Join Our Exclusive Webinar This Friday

Cherished investors and subscribers,

This is a friendly reminder to invite you to our webinar on The Future of Mental Health Therapeutics derived from the psychedelic prodrug psilocybin, presented by our newly appointed Chief Innovation Officer, Dr. Riyad Domingo.
We recently announced the appointment of Dr. Riyad Domingo as Chief Innovation Officer of M2Bio Sciences. Dr. Domingo holds a Ph.D. in Medical Biochemistry with a focus on drug discovery and development from the Institute of Infectious Diseases and Molecular Medicine at the University of Cape Town.

This Friday, October 1st, 2021 at 3PM South Africa time, he will provide an overview of the company's innovative work leveraging the power of artificial intelligence and additive manufacturing in the drug discovery and development process.

To join the event, register using the following link: 


Jeff Robinson and Dr. Anna Morera Leralta
Twitter Twitter
LinkedIn LinkedIn
Facebook Facebook
Instagram Instagram

                     M2Bio Sciences, Inc.  |  12 Park Road Place, 9 Park Road, Gardens    |  Cape Town 8001, South Africa


Copyright © |2021| |OTCMKTS: WUHN| or its affiliates. All rights reserved. M2bio Sciences, Dr. AnnaRx, Medspresso, the logo, and all other related logos are trademarks of M2Bio Sciences, Inc. or its affiliates.

You've received this email because you opted in via our website or have shown an interest in the past. If you wish to change how you receive these emails?
You can update your preferences or unsubscribe from this list.


Email Marketing Powered by Mailchimp